Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 9Colonic Neoplasms 5Ovarian Neoplasms 3Melanoma 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Breast Neoplasms 3Stomach Neoplasms 2Liver Neoplasms 2Fibrolamellar hepatocellular carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms, Squamous Cell 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Diabetes Mellitus, Insulin-Dependent, 12 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Merkel Cell 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 44Fluorouracil 16Cisplatin 15Oxaliplatin 13Capecitabine 11Paclitaxel 10lenvatinib 8Leucovorin 8Irinotecan 6Docetaxel 6trifluridine tipiracil drug combination 3regorafenib 3Saline Solution 3Levoleucovorin 3Gemcitabine 3Bevacizumab 3patritumab deruxtecan 2Trastuzumab 2S 1 (combination) 2Radiotherapy 2Cetuximab 2Carboplatin 2zanidatamab 1vicriviroc 1tremelimumab 1tislelizumab 1tipiracil 1spartalizumab 1sinoporphyrin sodium 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × poly ICLC × Gastrointestinal × Clear all
NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Augusta University

Phase 1/2 Completed
42 enrolled 13 charts
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡